Both in Pharmaceuticals
Enveric Biosciences vs Skye Bioscience
Over the past year ENVB returned −78.8% and SKYE returned −89.8%; their daily moves had a correlation of 0.03.
ENVB −78.8% SKYE −89.8%Growth of $1, one year, split-adjusted
| Metric | ENVB | SKYE |
|---|---|---|
| Price | $1.50 | $1.22 |
| Market cap | $6.7M | $5.4M |
| Today | +3.45% | −7.58% |
| 1 month | −0.7% | −29.5% |
| 6 months | −56.9% | −82.6% |
| Year to date | −58.7% | −79.7% |
| 1 year | −73.7% | −90.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $8.3M | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 48.5% | 616.4% |
| Short % of float | 0.9% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).